Achilles Therapeutics PLC News

ACHLDelisted Stock  USD 1.48  0.01  0.68%   
About 52% of Achilles Therapeutics' institutional investors are presently thinking to get in. The analysis of overall sentiment of trading Achilles Therapeutics PLC stock suggests that some investors are interested at this time. Achilles Therapeutics' investing sentiment shows overall attitude of investors towards Achilles Therapeutics PLC.
  
over a week ago at news.google.com         
Achilles Therapeutics stock hits 52-week high at 1.41 - Investing.com
Google News at Macroaxis
over three weeks ago at gurufocus.com         
Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
Achilles Therapeutics plc Short Interest Up 1,280.4 percent in February
news
over a month ago at news.google.com         
Achilles Therapeutics plc Short Interest Down 52.8 percent in January - MarketBeat
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Financial Comparison MiNK Therapeutics and Achilles Therapeutics
news
over a month ago at simplywall.st         
February 2025s Promising Penny Stocks On US Exchanges
Simply Wall St News at Macroaxis
over a month ago at news.google.com         
12 Health Care Stocks Moving In Tuesdays Pre-Market Session - Benzinga
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Achilles Therapeutics plc Short Interest Update
news
over a month ago at news.google.com         
Achilles Therapeutics receives Nasdaq notice for non-compliance - MSN
Google News at Macroaxis
over two months ago at benzinga.com         
Achilles Therapeutics Announces 12M AstraZeneca Deal, Plans Job Cuts
benzinga news
over two months ago at gurufocus.com         
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
Gurufocus Stories at Macroaxis
over three months ago at news.google.com         
Achilles Therapeutics Reports Q3 2024 Financial Results - TipRanks
Google News at Macroaxis
over three months ago at gurufocus.com         
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
Gurufocus Stories at Macroaxis
over three months ago at thelincolnianonline.com         
Short Interest in Achilles Therapeutics plc Drops By 25.1
news
over three months ago at news.google.com         
Syncona Portfolio Ltds Strategic Acquisition of Autolus Therape - GuruFocus.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Achilles Therapeutics that are available to investors today. That information is available publicly through Achilles media outlets and privately through word of mouth or via Achilles internal channels. However, regardless of the origin, that massive amount of Achilles data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Achilles Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Achilles Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Achilles Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Achilles Therapeutics alpha.

Achilles Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Achilles Therapeutics Announces 12M AstraZeneca Deal, Plans Job Cuts
12/24/2024
2
12 Health Care Stocks Moving In Tuesdays Pre-Market Session - Benzinga
02/04/2025
3
Achilles Therapeutics stock hits 52-week high at 1.41 - Investing.com
03/13/2025
Check out Achilles Therapeutics Hype Analysis, Achilles Therapeutics Correlation and Achilles Therapeutics Performance.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Achilles Stock

If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.